September 14, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee

• September 14, 2016: Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee
• Psychopharmacologic Drugs Advisory Committee Roster for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)
• Drug Safety and Risk Management Advisory Committee Roster for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)
• Briefing Information for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)
• Webcast Information for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)
• Final Agenda for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)
• Final Questions for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)
• Final Meeting Roster for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)
• Slides for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)
• Minutes for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)
• Transcript for the September 14, 2016 Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management Advisory Committee (DSaRM)
• 2016 Meeting Materials, Drug Safety and Risk Management Advisory Committee

March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee

• March 29, 2016: Meeting of the Psychopharmacologic Drugs Advisory Committee Meeting Announcement
• Committee Roster for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Briefing Information for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Webcast Information for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Final Agenda for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Final Questions for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Final Meeting Roster for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Slides for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Minutes for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Transcript for the March 29, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)

February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee

• February 3, 2016: Psychopharmacologic Drugs Advisory Committee Meeting Announcement
• Committee Roster for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Briefing Information for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Webcast Information for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Audio file for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Final Questions for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) (AM Session)
• Final Questions for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) (PM Session)
• Final Meeting Roster for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Slides for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Minutes for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Audio file for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Transcript for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) (AM Session)
• Transcript for the February 3, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) (PM Session)

January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee

• January 12, 2016: Psychopharmacologic Drugs Advisory Committee Meeting Announcement
• Committee Roster for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Briefing Information for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Webcast Information for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Final Agenda for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Final Questions for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Final Meeting Roster for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Slides for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Minutes for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)
• Transcript for the January 12, 2016 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)